Dor Yeshorim Expands to the Sephardic Community

Total Page:16

File Type:pdf, Size:1020Kb

Dor Yeshorim Expands to the Sephardic Community SALUTE TO THE HIGH SCHOOL GRADUATES OF 2016 > P. 42 Volume XV Number 10 Volume COMMUNITYSivan - Tammuz 5776 July 2016 Safeguarding Jews From Genetic Disease: DOR YESHORIM EXPANDS TO THE SEPHARDIC COMMUNITY THE BLIND FAITH A Tribute to Red Nesser – CONUNDRUM The Ultimate Team Player WORDS OF Dave Gordon RABBI ELI J. MANSOUR MEIRA BAUMAN Safeguarding Jews From Genetic Disease: DOR YESHORIM EXPANDS TO THE Fresh SEPHARDIC COMMUNITY Defined ITS FOUNDING the health of Klal Yisrael’s future of their baby’s symptoms. Panic-stricken, Thirty years ago, genetic disease was a generations. With much dedication, he Rabbi Ekstein and his wife began a long taboo topic – a reality which added even sought the haskama (encouragement) of and arduous journey, going from doctor more heartache to already suffering families. Gedolim and lay leaders alike, across many to doctor, in search of a diagnosis and a While today, the words “genetic disease” communities. He wanted, Dor Yeshorim to cure for their precious baby. After months are still associated with tremendous pain become an entity that could help all Jews, of heart-rending agony in the face of the and anguish, no longer is the fear and across every denomination. Eventually, he unknown, they were finally given a proper stigma of the disease a debilitating factor. hoped to eliminate genetic diseases from diagnosis: Tay Sachs disease. That’s all due to one courageous individual, Klal Yisrael for good. “That very minute when we first received Rabbi Josef Ekstein, who, after, rachmana “As Jews, we’ve undergone many the diagnosis from the medical experts,” l’tzlan, losing four children to Tay Sachs challenges and hardships throughout the explained Rabbi Ekstein, “was the first disease, set out on a heroic mission to build long years we’ve endured in galut,” Rabbi time that my wife and I had ever heard of a fortress of education, prevention and Ekstein said. “Yet, when a parent loses the words ‘Tay Sachs.’ From that moment research around genetic disease. Its name? a child, rachmana l’tzlan, a nightmare I on, what was once a carefree and happy that Dor Yeshorim. wish on no one, is the most painful parenthood evolved into a frightening Reservations Seating from experience of all. It’s a tragedy I fervently maze of medical visits, with us in and out At Estreia, we recognize that locally-grown produce adds an Despite the noble cause it was built to 732.994.7878 5:00pm to 10:30pm serve, Dor Yeshorim did not have an easy start. hope and pray that no other parent should of hospitals and facilities, watching our entirely new dimension to the dining experience. Taste the crisp, [email protected] Sunday - Thursday Rabbi Ekstein’s mission to ensure that not a ever have to undergo. Especially not if precious little boy regress. garden freshness of our farm-to-table ingredients. single child in Klal Yisrael would struggle with it’s one that, with a minimum effort of “A short while later, Hashem entrusted hishtadlut, could easily be prevented.” a beautiful baby girl into our hands. Yet, 978 River Avenue View our complete menu genetic disease was met with resistance at Lakewood, NJ 08701 at www.estreia978.com first. People knew so little about the concept When Rabbi Ekstein’s firstborn son turned our blissful joy at the birth of our second You'll Understand the Difference. and feared what they didn’t understand. For just six months old, he began to display precious neshama was short-lived, as she, these reasons, they were reluctant to let Dor signs of extremely delayed development. too, began showing those all-too familiar Yeshorim into their lives. After their regular pediatrician was unable signs of regression that we knew only so Yet, Rabbi Ekstein, with superhuman to label the cause, Rabbi Ekstein and his well from our son. strength, stamina and determination, wife began to visit other professionals, each “Our third child was, baruch Hashem forged forward in his mission to safeguard of whom could not pinpoint the source born a completely healthy baby and did Supervised by the KCL - Mashgiach Temidi 30 COMMUNITY MAGAZINE not experience any of the same symptoms ITS PROGRAMS of her older siblings. But her next two Dor Yeshorim constantly seeks to siblings were also diagnosed with the reproduce and multiply its existing same debilitating and fatal disease that successes so as to prevent even more their oldest brother and sister were agony and suffering from pervading suffering from.” Klal Yisrael’s families. It heavily invests ITS ROOTS in ongoing genetic research to ensure that this dream remains a reality. In During this time, the resources and so doing, it has become responsible research available on genetic disease in for the identification of numerous general and Tay Sachs, in particular were disease-causing genetic mutations. primitive at best. Hundreds of families Dor Yeshorim’s acclaimed and proven were experiencing heartbreaking anguish premarital genetic screening program, of as they gave birth to children with Tay Sachs thirty-three years, is the most successful of and other genetic diseases. With nowhere its kind in the world! To date, Dor Yeshorim to turn to ease their burden and relieve has tested more than 427,500 individuals. some of their pain, these families chose to Under the direction of the Gedolei Hador, remain quiet about this genetic disease, so each individual that Dor Yeshorim tests they would not be stigmatized and denied is identified throughout the process by a shidduchim for their healthy children. unique, nine-digit identification number. Rabbi Ekstein knew it was time to create As part of its strict confidentiality policy, Dor massive change in the way genetic disease Yeshorim does not reveal the carrier status was researched and regarded. He is of the of any testee. This, in turn, helps reduce the firm belief that if “something that can be heartache and stigma that comes along with avoided, why not avoid it?” Not wanting the knowledge that one is a carrier of genetic others to experience the unspeakable disease. It also helps provide much-needed tragedies that he underwent, Rabbi Ekstein, peace of mind to individuals going through the together with other dedicated individuals, shidduchim process, who fear being a carrier of began to develop the blueprints for the genetic disease. entity that, today, is Dor Yeshorim. Dor Yeshorim screens tens of thousands ITS IMPACT of young men and women in 400 schools across the globe, making the genetic To date, Dor Yeshorim is responsible screening process simple for these for preventing over 4,760 families in Klal individuals. More than 25,000 individuals Yisrael from, rachmana l’tzlan, having are tested and close to 23,000 compatibility children born with genetic disease. This results are facilitated each year, through its organization, under the expert leadership highly efficient system. and guidance of Rabbi Ekstein, has helped The premarital genetic screening to eliminate Tay Sachs and many other program proceeds as follows: After a blood debilitating genetic diseases from the Jewish sample is drawn, each testee is given an community worldwide. identification number. Then, before a In fact, in light of Dor Yeshorim’s lifesaving couple meets, they exchange ID numbers, work, the Tay Sachs ward at Kingsbrook keying the information into Dor Yeshorim’s Jewish Medical Center in Brooklyn, New automated system. Within a few hours, York, once one of the largest Tay Sachs wards Dor Yeshorim calls them back with the in the world, has closed its doors for good, results. If their genetic makeups are due to a complete lack of admissions. The compatible, the couple may proceed with Director of Pediatrics at Kingsbrook Jewish the shidduch, secure in the knowledge Medical Center, Dr. Hua-Chin Chen, wrote that they will not have children affected a heartfelt letter to Rabbi Ekstein, thanking with the genetic diseases they tested for. him for his tireless work in eradicating this If, rachmana l'tzlan, they were not found disease. “I just wanted to write you a final to be compatible genetically, Dor Yeshorim chapter regarding [the] Tay Sachs disease,” will advise the couple on the dangers the letter read in part. “Through your of continuing with the match and offer aggressive genetic testing system to prevent support and guidance, as needed. this serious medical problem, we have Dor Yeshorim encourages those it eliminated this disease. Our last Tay Sachs screens to check shidduch compatibility patients passed away five years ago and before a couple meets for the first time there have been no admissions since. I am – because, of course, incompatibly is grateful for your success and the support of much harder to bear after an emotional the Jewish communities.” connection has been established. 32 COMMUNITY MAGAZINE ITS FAMILIES was to develop a comprehensive testing screened for both Dor Yeshorim’s Ashkenazic panel that would test Sephardim for the genetic and Sephardic panels. Those who were tested Dor Yeshorim does not for one moment diseases that they are susceptible to, in the by Dor Yeshorim before this time period should forget who its incredible and lifesaving hopes of eliminating the recurrence of genetic call the Dor Yeshorim office to update their work is for - the individual members of Klal disease from the Sephardic community, as well. information. An additional blood specimen is Yisrael. It aims to provide the utmost peace Dr. Ohad Birk, the head of the Genetics not needed, in most cases. of mind to our communities, doing all it can Institute at Soroka Medical Center, located in Since Dor Yeshorim’s announcement to assist families of children who, rachmana Be’er Sheva in Israel, believes that the dearth about the addition of its Sephardic testing l’tzlan, were born with genetic disorders.
Recommended publications
  • Mishpacha-Article-February-2011.Pdf
    HANGING ON BY A FRINGCOLONE:EL MORDECHAI FRIZIS’S MEMBERS COURAG THEEOUS LA SRESPONSET ACT OF THE TRIBE? FOR HIS COUNTRY OPEN MIKE FOR HUCKABEE SWEET SONG OF EMPATHY THE PRESIDENTIAL HOPEFUL ON WHAT FUELED HIS FIFTEENTH TRIP TO ISRAEL A CANDID CONVERSATION WITH SHLOIME DACHS, CHILD OF A “BROKEN HOME” LIFEGUARD AT THE GENE POOL HIS SCREENING PROGRAM HAS SPARED THOUSANDS FROM THE HORROR OF HIS PERSONAL LOSSES. NOW DOR YESHORIM’S RABBI YOSEF EKSTEIN BRAVES THE STEM CELL FRONTIER ON-SITE REPORT RAMALLAHEDUCATOR AND INNOVATOR IN RREALABBI YAAKOV TIME SPITZER CAN THES P.TILLA. FORM LIVA FISCESALLY RSOUNDAV STATE?WEI SSMANDEL’S WORDS familyfirst ISSUE 346 I 5 Adar I 5771 I February 9, 2011 PRICE: NY/NJ $3.99 Out of NY/NJ $4.99 Canada CAD $5.50 Israel NIS 11.90 UK £3.20 INSIDE The Gene Marker's Rabbi Yosef Ekstein of Dor Yeshorim Vowed that No Couple Would Know His Pain Bride When Rabbi Yosef Ekstein’s fourth Tay-Sachs baby was born, he knew he had two options – to fall into crushing despair, or take action. “The Ribono Shel Olam knew I would bury four children before I could take my self-pity and turn it outward,” Rabbi Ekstein says. But he knew nothing about genetics or biology, couldn’t speak English, and didn’t even have a high school diploma. How did this Satmar chassid, a shochet and kashrus supervisor from Argentina, evolve into a leading expert in the field of preventative genetic research, creating an Bride international screening program used by most people in shidduchim today? 34 5 Adar I 5771 2.9.11 35 QUOTES %%% Rachel Ginsberg His father, Rabbi Kalman Eliezer disease and its devastating progression, as Photos: Meir Haltovsky, Ouria Tadmor Ekstein, used to tell him, “You survived by the infant seemed perfect for the first half- a miracle.
    [Show full text]
  • CARRIER SCREENING: POPULATION DIFFERENCES, STIGMA, and the SPECTER of Co-Authored with EUGENICS Stephen Pemberton Tay Sachs KEITH WAILOO, PH.D
    CARRIER SCREENING: POPULATION DIFFERENCES, STIGMA, AND THE SPECTER OF Co-authored with EUGENICS Stephen Pemberton Tay Sachs KEITH WAILOO, PH.D. Disease Martin Luther King Jr. Professor Cystic Fibrosis RUTGERS UNIVERSITY Sickle Cell Disease DEPARTMENT OF HISTORY INSTITUTE FOR HEALTH, HEALTH CARE POLICY, AND AGING RESEARCH RESEARCH SUPPORTED BY: ETHICAL, LEGAL, AND SOCIAL ISSUES (ELSI) PROGRAM, NHGRI; and THE JAMES S. MCDONNELL FOUNDATION Lessons of the Past: • Balancing the screening interests of individuals, communities, and society? The importance of historical sensitivity and cultural competence among health practitioners who engage in screening • How to target screening to distinct populations? The challenge of “hidden” versus obvious subpopulations. One-size does not fit all; how screening relates to group values and concerns • In health care, knowing when screening is not the answer for some populations. Other goals: treatment and extension of life, relief. The importance of competent screening programs among populations whose group identities are invested in the maintenance of values that are distinctively different than that of the majority culture. TODAY: ONE HISTORICAL CASE STUDY (TAY-SACHS DISEASE), WITH SICKLE CELL DISEASE AND CYSTIC FIBROSIS AS BACKDROP CONTROVERSIES in CARRIER SCREENING, STIGMATIZATION, AND POPULATION – the case of sickle cell disease • LINUS PAULING 1968: “I have suggested that there should be tatooed on the forehead of every young person a symbol showing possession of the sickle cell gene or whatever other
    [Show full text]
  • Carrier Screening Panels for Ashkenazi Jews: Is More Better? Jennifer R
    March 2005 ⅐ Vol. 7 ⅐ No. 3 article Carrier screening panels for Ashkenazi Jews: Is more better? Jennifer R. Leib, MS1,2, Sarah E. Gollust, BA3,4, Sara Chandros Hull, PhD3,4, and Benjamin S. Wilfond, MD3,4 Purpose: To describe the characteristics of Ashkenazi Jewish carrier testing panels offered by US Laboratories, including what diseases are included, the labels used to describe the panels, and the prices of individual tests compared to the prices of panels for each laboratory. Methods: GeneTests (http://www.genetests.org) was searched for laboratories that offered Tay-Sachs disease testing. Information was obtained from laboratory web sites, printed brochures, and telephone calls about tests/panels. Results: Twenty-seven laboratories offered up to 10 tests. The tests included two diseases associated with death in childhood (Niemann-Pick type A and Tay-Sachs disease), five with moderate disability and a variably shortened life span (Bloom syndrome, Canavan disease, cystic fibrosis, familial dysautonomia, Fanconi anemia, and mucolipidosis type IV), and two diseases that are not necessarily disabling or routinely shorten the lifespan (Gaucher disease type I and DFNB1 sensorineural hearing loss). Twenty laboratories offered a total of 27 panels of tests for three to nine diseases, ranging in price from $200 to $2082. Of these, 15 panels cost less than tests ordered individually. The panels were described by 24 different labels; eight included the phrase Ashkenazi Jewish Disease or disorder and six included the phrase Ashkenazi Jewish Carrier. Conclusion: There is considerable variability in the diseases, prices, and labels of panels. Policy guidance for establishing appropriate criteria for inclusion in panels may be useful to the Ashkenazi Jewish community, clinicians, and payers.
    [Show full text]
  • Judaism, Genetic Screening and Genetic Therapy Part 2
    Jerusalem Science Contest החידון המדע הירושלמי Judaism, Genetic Screening and Genetic Therapy Part 2 The Jerusalem Science contest lecture on Judaism, Genetic Screening and Genetic Therapy – Part 2 1 Judaism, Genetic Screening and Genetic Therapy FRED ROSNER, M.D., F.A.C.P. OCTOBER/NOVEMBER 1998 NUMBER 5 & 6 VOLUME 65:406-413 From the Director, Department of Medicine, Mount Sinai Services at Queens Hospital Center, Jamaica, NY, and Professor of Medicine, Mount Sinai School of Medicine, New York, NY. Address correspondence to Fred Rosner, M.D., F.A.C.P., Queens Hospital Center, 82-68 164th Street, Jamaica, NY 11432 or address e-mail to: [email protected] Presented at the 8th annual International Conference on Jewish Medical Ethics. San Francisco, CA, February 15, 1997. Fred Rosner, M.D., F.A.C.P., Professor of Medicine at Mount Sinai School of Medicine, currently serves as the Director, Department of Medicine, Queens Hospital Center in New York City. Dr. Rosner, an internationally known authority on medical ethics, is the founding and former Chairman of the Medical Ethics Committee of the Medical Society of the State of New York and is the former Co-Chairman of the Medical Ethics Committee of the Federation of Jewish Philanthropies of New York. Dr. Rosner, a prolific writer, is the author of widely acclaimed books and articles on Jewish medical ethics and Jewish medical history. He also serves as a reviewer and editor for many medical journals. In part 2, we continue to review a presentation and essay by Dr. Fred Rosner delivered on February 15, 1997 at the 8th annual Conference on Jewish Medical Ethics, San Francisco, California.
    [Show full text]
  • JEWISH OBSERVER {ISSN) Ool!J-6Gl5 LS Pllbusih:O MO"Itllly J.:XCF.L't J111.Y & Allg!IST by !"!IE AGUOATH IS RAEL of AMERICA 4\! L~ROAOWAY, NEW YORK, NY !OOOJ
    • The ribbon, It's America's symbol for an urgent cause. first, there were pink ond purple ribbons to support medical research. Then, as our brave troops departed for distant shores, the yellow ribbons, and the red, white and blue, appeared everywhere. To that, we add the green Cucumber ribbon to support our kin.111 troops fighting for Ooroh's vital cause - saving Jewish neshamos. So display your green ribbon with pride. It's another important way to show you care. 1. • To get your free Cucumber ribbon dial extension 6038. f you were one of the 100.000+ participants at the Eleventh Siyum HaShas of Oaf Yomi here is your chance to relive that unforgettable expe­ Irience through a collection of CD ROMs. capturing all of the inspiring moments of the Siyum. f you were not fortunate to attend. you can now feel that awesome expe­ rience by seeing and hearing the inspiring words of our gedolim. and Icapture the excitement that so many witnessed and enjoyed. This commemorative five CD ROM set encased in an attractive customized binder. has been produced by popular request and is available for $39. 99 per set (plus $5.00 per set postage and handling.) Order Now! You'll treasure this historic event for years to come. An excellent gift item - order extra sets for friends and family! To: OAF YDMI COMMISSION • AGUDATH ISRAEL OF AMERICA • 42 Broadway. New York. NY 10004 Please send me set(s) of the Eleventh Siyum HaShas of Dal Yomi Commemorative CD ROM set. Iam enclosing a contribution of $39.99 for each set ordered • (plus $5.00 per set for postage and handling [USA addresses only]).
    [Show full text]
  • Fuzzy Logic and Preconceptional Genetic Carrier Screening-Revised
    Issue 1/2014 2341-0183 Fuzzy%Logic%and%Preconceptional%Genetic% Carrier%Screening! ! Julia&Inthorn1! 1!Institute!for!Medical!Ethics!and!History!of!Medicine,!Göttingen!University!Medical!Centre,!Germany! and!Centre!for!Research!Ethics!and!Bioethics,!Uppsala!University,!Sweden! ! Email:[email protected]! Abstract Medical(screening(programs(have(been(established(based(on(the(idea(of(early(treatment(and( prevention.( The( selection( of( tests( as( well( as( the( diseases( tested( for( that( are( included( in( a( screening( need( to( be( ethically( justified.( This( article( looks( at( criteria( for( screening( such( as( severity( of( a( disease( and( efficiency( of( a( test( and( their( applicability( for( newly( developed( preconceptional( genetic( carrier( screening.( Preconceptional( genetic( carrier( screening( can( be( used(by(couples(planning(a(pregnancy(in(order(to(learn(it(they(are(both(carriers(of(a(recessive( inherited(diseases(und(thus(have(an(increased(risk(of(having(an(affected(child.(It(is(argued(that( introducing( fuzzy( logic( helps( to( overcome( a( binary( logic( of( ethical( decisions( and( to( discuss( ethical( problems( connected( to( the( selection( of( diseases( for( preconceptional( genetic( carrier( screening( in( a( more( nuanced( way.( With( ongoing( research( about( the( relationship( between( genotype(and(phenotype(as(well(as(current(development(of(new(genetic(screening(methods(the( selection(of(tests(and(diseases(will(have(to(deal(with(knowledge(deficits(which(fuzzy(logic(can( help(to(handle.((( Submitted:!20/02/14.!Accepted!and!Published:!29/04/14 !Inthorn: Fuzzy Logic and Preconceptional! ! Genetic! Carrier Screening! !! APHSC 1:2014 DOI tbp – http://www.aphsc.org Page 1 of 10 © 2014 by the Authors; licensee ECSC.
    [Show full text]
  • Optional Ashkenazi Panel Brochure
    בס’’ד Fulfilling Our Responsibility To The Next Generation A VITAL PROGRAM THAT SAVES LIVES! The Dor Yeshorim mission: For over 30 years, Dor Yeshorim has successfully prevented the occurrence of genetic diseases in our NOW AVAILABLE: families. Since 1983, Dor Yeshorim with Hashem’s help NEW PANEL OF TESTS has successfully prevented genetic diseases from affecting our Jewish Community by conducting mass screenings in high schools, colleges, universities, FOR SEVEN ADDITIONAL yeshivas and seminaries worldwide- throughout the United States, Israel, Canada, Europe, and countless other orthodox Jewish communities. DEVASTATING AND The Dor Yeshorim genetic screening program was established to provide protection from Jewish genetic diseases, while safeguarding individuals from the potentiallY FatAL psychological stigma associated with knowing their carrier status. DISEASES To date, approximately 375,000 individual genetic screening tests have been performed, and nearly 2,000 potential couples have been spared the List of Diseases: agony of giving birth to a child or children with a 1. Bardet–Biedl Syndrome Type 2 (BBS2) devastating or fatal genetic disease. The birth of a sick child not only impacts the parents of this child 2. Nemaline Myopathy (NM) but also the siblings, grandpare nts and the extended 3. Dihyrolipoamide Dehydrogenase Deficiency (DLDD) family. B’H Dor Yeshorim has been able to spare over 4. Usher Syndrome Type 1 (USH1) 2,000 families the hardships associated with having such a child. 5. Joubert Syndrome (JBTS) DY benefits from
    [Show full text]
  • Finding Utility for Genetic Diagnostics in the Developing World
    Finding Utility for Genetic Diagnostics in the Developing World By Ridhi Tariyal B.S. Industrial Engineering, Georgia Institute of Technology (2002) M.B.A. Harvard Business School (2009) SUBMITTED TO THE HARVARD - MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREES OF MASTERS OF SCIENCE IN HEALTH SCIENCES AND TECHNOLOGY ARCHNES at the 4ASSACHUETFS ONS ITUTEj OF TFc, ooG MASSACHUSETTS INSTITUTE OF TECHNOLOGY MAR 9 1 2 11 September 2010 L @2010 Ridhi Tariyal. All rights reserved. IRARIES The author hereby grants MIT permission to reproduce and distribute publicly paper and electronic copies of thisthesis document in whole or in part. Signature of Author:"' H ard-MIT Division of Health $ciences and Technology, August 2010 Certified by: George Church Professor of Ge tics, Harvard Medical School, Director of the Center for Computational Genetics Thesis Supervisor Certified by: -Z-_==: - - Stan Lapidus Senior Lecturer, MIT Sloan School of Management Thesis Supervisor Accepted by: Ram Sasisekharan, PhD/Director, Harvard-MIT Division of Health Sciences and Technology/Edward Hood Taplin Professor of Health Sciences & Technology and Biological Engineering. ACKNOWLEDGEMENTS The idea behind this thesis was born in 2006 when I was working for a big pharmaceutical company and reading about the progress in genetics. I found myself spending more time thinking about the advances and challenges in the personalized medicine space than the immediate tasks and challenges in my employment. Since then, it has been a pleasure to move slowly but surely towards aligning my personal interests with my academic and professional pursuits. I would like to thank my classmates in school, my wonderful professors and my friends and family for brainstorming with me, encouraging me, answering endless questions about very personal genetic choices and offering unwavering support in this journey.
    [Show full text]
  • Dor Yeshorim
    בס"ד Dor Yeshorim Fulfilling Our Responsibility to the Next Generation Dor Yeshorim, for over 26 years, has had one mission: premarital program is the best application of preventive medicine and the most successful application of genetic sciences to date, anywhere in the The total elimination of the occurrences of recessive genetic illnesses. world. To accomplish this mission, Dor Yeshorim utilizes a program that does no harm to participants, avoids their stigmatization, and is guided by halachah. The Dor Yeshorim program has become an integral part of the shidduch process in the Torah observant Ashkenazi Jewish community worldwide. Under the direction of Gedolei Yisroel and the world’s foremost medical Over 300,000 individuals have, since its inception, participated in the experts, Dor Yeshorim has managed to eliminate the incidence of Tay program, with over 22,000 individuals being screened and joining the Sachs disease, as well as other recessive genetic diseases common to the program every year. To date, more than 1,600 marriages of couples, where Ashkenazi Jewish community, while zealously guarding the privacy and both parties were carriers of a genetic mutation, and therefore risked having dignity of Jewish families. affected children, have been avoided. The impact of the Dor Yeshorim program is indisputable. After over 26 years Today it’s a given that a potential choson or callah doesn’t arrive at a of activity there are virtually no children born with Tay Sachs disease! This marriage decision without first ascertaining genetic suitability. Using the accomplishment is evidenced by the fact that Kingsbrook Medical Center, in Dor Yeshorim program can prevent disasters in future generations.
    [Show full text]
  • The Demography of Devotion: Comparing Amish and Hasidic Jewish Religious Responses to Genetic Diseases
    The Demography of Devotion: Comparing Amish and Hasidic Jewish Religious Responses to Genetic Diseases A Senior Honors Thesis Presented in Partial Fulfillment of the Requirements for graduation with research distinction in Sociology in the undergraduate colleges of The Ohio State University by Andrea Lynne Nadel The Ohio State University May 2009 Project Advisor: Dr. Elizabeth Cooksey, Department of Sociology The author is indebted to Dr. Elizabeth Cooksey and Dr. Joseph Donnermeyer, who were invaluable not only for the Amish primary sources they provided, but also for the sagacity and guidance with which they enabled her to complete this research. Andrea Lynne Nadel ‐ Honors Thesis Introduction As minority religious groups in the United States, the Amish and Hasidim today share a great deal in common in terms of their ideological origins stemming from political turmoil in Europe, their history of persecution prior to arrival in the United States, their motivations for coming to America and their experiences since arrival. Both the Amish and the Hasidic Jews lived on the fringe of European society, and as a result they suffered bitterly at the hands of Europe's religious and political establishments. Early Amish and Hasidic leaders offered alternative ways for their respective faithful to journey spiritually regardless of their social standing. Subsequently, the promise of freedom from such persecution by moving to America was irresistible for both the Amish and the Hasidim, and both populations have flourished in this country since their arrival. The most compelling similarity between the Amish and the Hasidim, however, is that both groups are socially and genetically closed societies, making them uniquely susceptible to genetic diseases compared to the general population of the United States.
    [Show full text]
  • Molecular Screening for Diseases Frequent in Ashkenazi Jews: Lessons Learned from More Than 100,000 Tests Performed in a Commercial Laboratory Charles M
    May/June 2004 ⅐ Vol. 6 ⅐ No. 3 article Molecular screening for diseases frequent in Ashkenazi Jews: Lessons learned from more than 100,000 tests performed in a commercial laboratory Charles M. Strom, MD, PhD, Beryl Crossley, MD, Joy B. Redman, MS, Franklin Quan, PhD, Arlene Buller, PhD, Matthew J. McGinniss, PhD, and Weimin Sun, PhD Purpose: To determine the frequency of carriers of Ashkenazi Jewish (AJ) genetic diseases in the US population and compare these numbers with previously published frequencies reported in smaller more isolated cohorts. Meth- ods: A database containing more than 100,000 genotyping assays was queried. Assays for 10 separate AJ genetic diseases where comparisons were made with published data. Results: As expected, we observed lower carrier frequencies in a general, US population than those reported in literature. In 2427 patients tested for a panel of 8 AJ diseases, 20 (1:121) were carriers of two diseases and 331 (1:7) were carriers of a single disease. Fifty-three of 7184 (1:306) individuals tested for Gaucher disease had 2 Gaucher Disease mutations indicating a potentially affected phenotype. Conclusions: As the number of AJ diseases increases, progressively more individuals will be identified as carriers of at least one disease. Genet Med 2004:6(3):145–152. Key Words: Ashkenazi Jews, genetic diseases, population screening The Jewish people arose in the Middle East during the TSD, Canavan Disease (CD) in 1998,3 and Cystic Fibrosis (CF) Bronze Age and have existed as a continuous community until in 2001.4 ACMG
    [Show full text]
  • Winning the War Against Genetics
    WINNING THE WAR AGAINST GENETIC DISEASES One Man’s Life’s Mission PART I 18 July 22, 2015 Thirty years ago people weren’t aware of Tay-Sachs, the terrifying genetic disease that plagued Ashkenazic Jewry — because the stigma in aff ected families was so great that they would do everything possible to conceal the truth about their children who inherited a genetic illness. Today the young people in our community — including those at the stage of shidduchim — aren’t even aware of Tay-Sachs because it has been rendered virtually extinct, thanks to one man with a vision, who has fueled his Herculean eff orts with his immense suff ering and with great siyatta diShmaya. As Dor Yeshorim marks 30 years since its founding, Inyan was treated to an exclusive interview with Reb Yosef Ekstein, its venerated founder. With powerful faith and an indomitable spirit he continues to change the landscape of Reb Yosef Ekstein genetic diseases in Jewish communities the world over. BY YITZCHOK SHTEIERMAN 6 Av 5775 19 WINNING THE WAR AGAINST GENETIC DISEASES ‘What Do We Know?’ Reb Yosef Ekstein welcomed Inyan to the Dor Yeshorim “WHEN OUR SON offi ces in Williamsburg where a staff of dedicated professionals work every day to ensure the mission that he promised to execute 30 years ago: that not one more couple in Klal Yisrael, Heaven forbid, should know the anguish that he and his family STOPPED DEVELOPING have endured. Among the employees of Dor Yeshorim are some who carefully examine tests and provide compatibility results, while AND LATER ON STARTED others fi eld the many delicate issues relating to individuals concerned with genetic diseases occurring in their families and helping them avert the worst.
    [Show full text]